Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict
Pfizer shares closed at $23.60 on Sept. 25, 2025, down 9% year-to-date and 18% from a year ago, near the bottom of their 52-week range. The dividend yield has risen above 7% as the stock slumped. In September, Pfizer announced a $7.3 billion acquisition of Metsera and reported strong Phase 3 results for a new COVID-19 vaccine. A key court hearing on Depo-Provera lawsuits is set for Sept. 29.